Articles by Kyle Poplin
-
Guest Articles
Friday
November 11
2016James Militzer / Scott Anderson / Kyle Poplin
Weekly Roundup: Social Impact Sector Reacts to Trump With Fear, Uncertainty … Room for Hope?
It may be hard to believe – and even harder for some to accept – but Donald Trump is now the most powerful man in the world. And like many, the social business and global development world was, shall we say, taken aback by his victory this week. As the new reality sinks in and leaders and commentators try to make sense of his election, we’ve compiled a few of their more memorable reactions.
- Categories
- Social Enterprise
-
Friday
November 4
2016James Militzer / Kyle Poplin / Scott Anderson
Weekly Roundup: Jill Stein’s SRI Controversy; Culture Change as Opportunity; Mobile Money’s Hungry
The hubbub about Green Party presidential candidate Jill Stein's insufficiently green investments might seem like a tempest in a teapot ... but it could signal an important shift; changing attitudes and rising disposable incomes in Kenya are opening possibilities for insurance firms; and research shows mobile money's driving a price revolution in international remittances. That, and more, in this week's Roundup.
- Categories
- Energy, Health Care, Investing, Technology
-
Guest Articles
Friday
October 28
2016Scott Anderson / James Militzer / Kyle Poplin
Weekly Roundup: Pondering Vice President Bill Gates (Thanks, WikiLeaks), How Buyers Lag Sellers, and FICO Going Big – Real Big
Can you imagine Vice President Bill Gates? We can. That's only part of our Weekly Roundup, which also includes peeks at consumer purchases – or lack therof – from social enterprises; an effort to increase access to credit for over 3 billion people around the globe; and a program that had money, recognition and everything it needed to succeed – except customers.
- Categories
- Social Enterprise
-
Guest Articles
Friday
October 21
2016Scott Anderson / Kyle Poplin / James Militzer
Weekly Roundup: A 1,030-Enterprise Survey, a Cuba/U.S. Collaboration, and a ‘Big Bet’ Primer
An expansive survey of social enterprises, a new health care collaboration between some old Cold War rivals, and an ambitious exploration of the challenges of "big bets" in philanthropy highlight this week's roundup of social business and global development news.
- Categories
- Agriculture, Education, Health Care, Social Enterprise
-
Friday
October 14
2016Kyle Poplin / Scott Anderson / James Militzer
Weekly Roundup: $5 Beats Free, SunFunder Rises, and Asia’s Investors Love Impact
Why it's not crazy for a global health organization to refuse free vaccines, where the world's most socially conscious investors live, which major funder might be planning to alter some old investment restrictions, and what's needed to support the Sustainable Development Goals. That and more; it's all here in our Weekly Roundup.
- Categories
- Health Care
-
Friday
October 7
2016Kyle Poplin / James Militzer / Scott Anderson
Weekly Roundup: Preventing Zika, Improving Microfinance and Percolating Progress
It’s not too early to start thinking of creative differential pricing strategies that might help poor people afford a Zika vaccine; it's not too late for microfinance to regain some of the allure it's lost in recent years; and the time is just right for East Africa to up its coffee production game. Read all about these items, and more, in our Weekly Roundup.
- Categories
- Uncategorized
-
Guest Articles
Friday
September 30
2016Kyle Poplin / Scott Anderson / James Militzer
Weekly Roundup: PSI for Profit, a Slowing ‘Pulse’ in Africa and Medical Tourism on Steroids
The non-profit Population Services International (PSI) announces the launch of a for-profit business in India, sub-Saharan Africa braces for "the lowest growth in more than 20 years," and Obamacare generates some unintended – and potentially exciting – consequences. We discuss these and other issues in our weekly roundup of social business and global development news.
- Categories
- Health Care, Investing, Social Enterprise
-
Guest Articles
Tuesday
September 27
2016The ‘Treacherous’ Transition from a Great Tech Idea to Sustainable Business
Hyrax Biosciences recently developed Exatype, a software solution that enables health care workers to quickly and affordably determine HIV positive patients’ responsiveness to treatment. In this Q&A, Dr. Kirsten Miller-Duys, business development lead, discusses Exatype’s implications for global health, plans to turn it into a sustainable business, and Africa's emerging tech sector.
- Categories
- Health Care, Social Enterprise